NCT05733637View on ClinicalTrials.gov

HRAD-Vascular Access

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

June 8, 2023

Primary Completion Date

June 11, 2023

Study Completion Date

June 10, 2024

Conditions
AnxietyVascular Access
Interventions
OTHER

No intervention

There will be no intervention apply to study participants.

Trial Locations (1)

94304

Lucile Packard Childrens Hospital Stanford, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT05733637 - HRAD-Vascular Access | Biotech Hunter | Biotech Hunter